BRNX (BRNX) Stock Price & Analysis
BRNX (BRNX) fell 26.32% to USD 2.24 as of September 8, 2026 at 03:29 UTC, according to Nexqual real-time market data.
BRNX last closed at USD 3.04; the session ranged USD 2.17–2.87 on volume of 3,914,152 shares. Market capitalization is $1.61M, with a 52-week range of USD 2.06–512.4 (NCM). Source: Nexqual, September 8, 2026 at 03:29 UTC.
Key Statistics (as of September 8, 2026 at 03:29 UTC)
| Price | USD 2.24 |
|---|---|
| Change | ▼ 26.32% (down) |
| Previous Close | USD 3.04 |
| Open | USD 2.83 |
| Day Range | USD 2.17 – 2.87 |
| 52-Week Range | USD 2.06 – 512.4 |
| Volume | 3,914,152 shares |
| Market Cap | $1.61M |
| Exchange | NCM |
Technical Analysis (BRNX)
Nexqual's technical model rates BRNX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 03:29 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.91 (neutral) |
| vs SMA50 | Below (USD 3.98) |
| MACD | -0.21 (negative) |
Analyst Ratings (BRNX)
Wall Street analysts rate BRNX "None", per Nexqual as of September 8, 2026 at 03:29 UTC.
| Consensus Rating | None |
|---|
Earnings (BRNX)
Source: Nexqual, September 8, 2026 at 03:29 UTC.
Financials & Fundamentals (BRNX)
| Total Revenue | $387,000 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -3291.47% |
| Profit Margin | +0.00% |
| ROE | -348.50% |
| Debt / Equity | 167.23 |
| Current Ratio | 1.33 |
| Total Cash | $4.91M |
| Total Debt | $5.84M |
| Free Cash Flow | $-5.63M |
Source: Nexqual, September 8, 2026 at 03:29 UTC.
Financial Health Score (BRNX)
Nexqual rates BRNX's overall financial health "Weak" across five dimensions, as of September 8, 2026 at 03:29 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $5M cash vs $6M debt |
| Cash Flow | Weak — Operating cash flow -$10M |
| Efficiency | Critical — ROE -348%, ROA -65.2% |
Ownership (BRNX)
| Insider Ownership | +0.27% |
|---|---|
| Institutional Ownership | +0.79% |
| Shares Outstanding | 720,888 |
| Float | 23,843 |
| Short % of Float | +34.52% |
Source: Nexqual, September 8, 2026 at 03:29 UTC.
Leadership (BRNX)
BRNX is led by Ofir Zimmerman (age 49), Chief Financial Officer, per Nexqual as of September 8, 2026 at 03:29 UTC.
| Chief Financial Officer | Ofir Zimmerman (age 49) |
|---|
Major Backers & Investors (BRNX)
Notable institutional backers of BRNX include UBS Group AG, Citadel, according to Nexqual as of September 8, 2026 at 03:29 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 1.39% |
| Citadel | 0.31% |
Source: Nexqual, September 8, 2026 at 03:29 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SVRE | SaverOne 2014 Ltd. | USD 2.61 | ▼ 9.06% |
| NEXR | Nexera Technologies Ltd | USD 1.7 | ▼ 8.11% |
| GCTK | GlucoTrack, Inc. | USD 2.98 | ▼ 15.58% |
| AKAN | Akanda Corp. | USD 3.35 | ▼ 10.43% |
| MGRX | Mangoceuticals, Inc. | USD 0.41 | ▲ 7.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:29 UTC. This page is informational and not investment advice.